Wave life sciences and gsk announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets

Wave receives upfront payment of $170 million in cash and equity, also eligible to receive milestone payments and royalties

WVE Ratings Summary

WVE Quant Ranking